israeli drugmaker

Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial

By Bill Berkrot May 18 – Tiny Israeli drugmaker Oramed Pharmaceuticals Inc on Wednesday said its experimental oral insulin succeeded in significantly reducing night-time blood glucose in patients with type 2 diabetes, according to initial data from a midstage trial. The result is likely to surprise many skeptics who did not believe insulin could be

[ Read More ]